IRIS UniCatt

Bellesi, Silvia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.938
NA - Nord America 2.479
AS - Asia 1.093
SA - Sud America 216
AF - Africa 45
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.777
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.424
DE - Germania 987
SE - Svezia 489
CN - Cina 425
IT - Italia 394
SG - Singapore 359
BR - Brasile 192
PL - Polonia 189
FR - Francia 186
GB - Regno Unito 142
FI - Finlandia 128
UA - Ucraina 117
IE - Irlanda 106
IN - India 76
ID - Indonesia 72
RU - Federazione Russa 55
CA - Canada 50
KR - Corea 28
AT - Austria 25
JP - Giappone 22
TW - Taiwan 22
CI - Costa d'Avorio 21
CZ - Repubblica Ceca 20
TR - Turchia 20
BE - Belgio 19
IR - Iran 12
NL - Olanda 12
HK - Hong Kong 11
MA - Marocco 9
GR - Grecia 8
IL - Israele 8
LT - Lituania 8
AR - Argentina 7
ES - Italia 7
CH - Svizzera 6
PT - Portogallo 6
VN - Vietnam 6
CO - Colombia 5
MY - Malesia 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
CL - Cile 4
EC - Ecuador 4
EE - Estonia 4
EG - Egitto 4
HU - Ungheria 4
KG - Kirghizistan 4
RO - Romania 4
TN - Tunisia 4
ZA - Sudafrica 4
BG - Bulgaria 3
IQ - Iraq 3
LV - Lettonia 3
MX - Messico 3
NO - Norvegia 3
PK - Pakistan 3
RS - Serbia 3
AL - Albania 2
BD - Bangladesh 2
DK - Danimarca 2
DZ - Algeria 2
NP - Nepal 2
PE - Perù 2
TH - Thailandia 2
AM - Armenia 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CY - Cipro 1
EU - Europa 1
IS - Islanda 1
JM - Giamaica 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MT - Malta 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
PY - Paraguay 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 6.777
Salva come PNG Salva come JPEG
Città #
Chandler 482
Singapore 232
Ashburn 194
Warsaw 182
Munich 134
Fairfield 116
Dublin 105
Jacksonville 90
San Mateo 81
Houston 76
Rome 76
Helsinki 75
New York 72
Jakarta 71
Beijing 67
Nanjing 64
Wilmington 64
Dearborn 60
Ann Arbor 58
Woodbridge 53
Nürnberg 50
Seattle 50
The Dalles 50
Marseille 46
Milan 43
Moscow 43
Boston 40
Los Angeles 40
Bremen 37
Cattolica 37
Hefei 35
Princeton 34
Lancaster 32
Nanchang 29
Seoul 27
Frankfurt am Main 26
Redwood City 24
Hyderabad 23
London 22
Abidjan 21
Chicago 21
Nuremberg 21
Cambridge 20
Lawrence 20
Boardman 18
Guangzhou 18
Toronto 18
Brno 17
Brussels 17
Hangzhou 17
Leawood 16
São Paulo 15
Vienna 14
Tianjin 13
Düsseldorf 12
Fremont 12
Turku 12
Changsha 11
Izmir 11
Lappeenranta 11
Shanghai 11
Lauterbourg 10
Norwalk 10
Santa Clara 10
Belo Horizonte 9
Florence 9
Hong Kong 9
Kunming 9
Kyoto 9
San Francisco 9
Auburn Hills 8
Hebei 8
Pune 8
Redmond 8
Rio de Janeiro 8
Augusta 7
Brooklyn 7
Falkenstein 7
Jiaxing 7
North Bergen 7
Ottawa 7
San Diego 7
Washington 7
Zhengzhou 7
Enterprise 6
Kish 6
Mountain View 6
Phoenix 6
Romainville 6
Shenyang 6
Wroclaw 6
Andover 5
Barletta 5
Bologna 5
Philadelphia 5
Portsmouth 5
University Park 5
Arezzo 4
Bexley 4
Bishkek 4
Totale 3.657
Salva come PNG Salva come JPEG
Nome #
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 372
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 294
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 279
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 217
Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies 216
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis 183
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 177
MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES 177
Correlation between paraproteinaemia and viral reactivation after allo-SCT 153
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 148
Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial 142
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 139
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 138
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 136
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 134
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 132
Prospective evaluation of Epstein-Barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 130
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 115
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 114
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 111
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 110
Prospective evaluation of epstein-barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 107
Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation 107
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 105
Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment 101
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 99
The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network ‘Rete Ematologica del Lazio per i Linfomi’ (RELLI) 97
Chlorambucil plus Rituximab as Front-Line Therapy in Elderly/Unfit Patients Affected by B-Cell Chronic Lymphocytic Leukemia: Results of a Single-Centre Experience 95
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 92
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 92
Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma 88
PE_PGRS3 ensures provision of the vital phospholipids cardiolipin and phosphatidylinositols by promoting the interaction between M. tuberculosis and host cells 85
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 84
Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma 82
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 77
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients 77
PE_PGRS3 of Mycobacterium tuberculosis is specifically expressed at low phosphate concentration, and its arginine-rich C-terminal domain mediates adhesion and persistence in host tissues when expressed in Mycobacterium smegmatis 76
Extramedullary Involvement in Acute Myeloid Leukemia. A Single Center Ten Years' Experience 76
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide :does graft cell content have an impact on main clinical outcomes? 73
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 73
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 73
Myeloid sarcoma with megakaryoblastic differentiation mimicking a sellar tumor 70
CD200 and prognosis in chronic lymphocytic leukemia: Conflicting results 67
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 67
Remission of acquired von Willebrand syndrome in a patient with chronic lymphocytic leukemia treated with venetoclax 66
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide: does graft cell content have an impact on main clinical outcomes? 66
Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience 61
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry 59
Chlorambucil PLUS Rituximab As FRONT-LINE THERAPY in Elderly or Unfit Patients Affected by B-CELL Chronic Lymphocytic Leukemia: Results of A Single-Centre Retrospective Analysis 57
Severe cmv infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in a mantle cell lymphoma old patient 57
Unlocking Predictive Power: Quantitative Assessment of CAR-T Expansion with Digital Droplet Polymerase Chain Reaction (ddPCR) 51
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 50
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 49
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 47
Novel Targets and Advanced Therapies in Diffuse Large B Cell Lymphomas 46
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 46
Acute erythroid leukemia with TP53 mutation and BCR/ABL1: challenges in classification and management 45
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 44
CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia 43
Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience 43
Digital morphology compared to the optical microscope: A validation study on reporting bone marrow aspirates 42
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 41
Day +60 WT1 assessment on CD34 selected bone marrow better predicts relapse and mortality after allogeneic stem cell transplantation in acute myeloid leukemia patients 39
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-t Cells 38
External validation of the accuracy of 'CLLflow score' 35
Evaluation of the Toxic Activity of the Graphene Oxide in the Ex Vivo Model of Human PBMC Infection with Mycobacterium tuberculosis 34
Unraveling the potential of graphene quantum dots against Mycobacterium tuberculosis infection 33
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 32
The CD4/CD8 ratio of infused CD19-CAR-T is a prognostic factor for efficacy and toxicity 32
Endoscopic Ultrasound-Guided Fine Needle Biopsy in the Diagnostic Work-Up of Deep-Seated Lymphadenopathies and Spleen Lesions: A Monocentric Experience 31
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 29
The Role of Fecal Microbiota Transplantation in the Allogeneic Stem Cell Transplant Setting 29
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T) 22
Discrepancy between recipient and donor rs4364254 heparanase single nucleotide polymorphism impacts graft-versus-host disease after allogeneic stem cell transplant 22
The Impact of Graft CD3 Cell/Regulatory T Cell Ratio on Acute Graft-versus-Host Disease and Post-Transplantation Outcome: A Prospective Multicenter Study of Patients with Acute Leukemia Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation 20
Cord blood resilience in a patient with relapsing Ph + B lymphoblastic acute leukemia after hematopoietic stem cell transplantation 19
Implications of Genetic, Biological and Clinical Parameters in Patients With Richter Syndrome: A Monocentric Experience 7
Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real-life experience 6
Totale 6.921
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.055
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.055
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020139 0 0 0 0 0 0 0 0 0 0 96 43
2020/2021611 33 44 36 50 71 53 41 26 44 42 143 28
2021/2022619 49 32 7 14 33 20 18 83 33 64 116 150
2022/20231.381 203 193 87 232 93 138 95 96 139 43 45 17
2023/2024738 33 181 28 41 26 100 54 54 10 29 86 96
2024/20251.647 65 61 118 101 169 108 145 92 241 185 362 0
Totale 6.921